INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹565 Cr | ₹611 Cr | ₹489 Cr | ₹440 Cr | ₹199 Cr |
What is the latest Total Current Liabilities ratio of INDEGENE ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹565 Cr |
Mar2024 | ₹611 Cr |
Mar2023 | ₹489 Cr |
Mar2022 | ₹440 Cr |
Mar2021 | ₹199 Cr |
How is Total Current Liabilities of INDEGENE Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹565 Cr | -7.60 | |
Mar2024 | ₹611 Cr | 24.90 | |
Mar2023 | ₹489 Cr | 11.05 | |
Mar2022 | ₹440 Cr | 120.85 | |
Mar2021 | ₹199 Cr | - |
Compare Total Current Liabilities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,388.0 Cr | 2.7% | -2.3% | -17.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,370.0 Cr | 0.7% | 0.4% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,087.0 Cr | -1.7% | 2% | 16.7% | Stock Analytics | |
CIPLA | ₹126,308.0 Cr | -0.9% | 5.3% | -3.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,614.0 Cr | -0.1% | 0.6% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,845.0 Cr | 4.1% | 7.6% | -3% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | 2.7% |
-2.3% |
-17.2% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses